Triangle Securities Wealth Management Bristol Myers Squibb CO Transaction History

Triangle Securities Wealth Management

$374 Million
Q4 2024

A detailed history of Triangle Securities Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Triangle Securities Wealth Management holds 16,767 shares of BMY stock, worth $936,101. This represents 0.25% of its overall portfolio holdings.

Number of Shares

16,767

Previous 18,266 8.21%

Holding current value

$936,101

Previous $945,000 0.32%

% of portfolio

0.25%

Previous 0.25%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$51.92 - $59.94 $77,828 - $89,850	-1,499 Reduced 8.21%	16,767 $948,000
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $430,073 - $561,177	-10,844 Reduced 37.25%	18,266 $945,000
Q2 2024 Jul 10, 2024	SELL	$40.25 - $52.99 $161,362 - $212,436	-4,009 Reduced 12.1%	29,110 $1.21 Million
Q1 2024 Apr 10, 2024	BUY	$47.98 - $54.4 $126,379 - $143,289	2,634 Added 8.64%	33,119 $1.8 Million
Q4 2023 Jan 10, 2024	SELL	$48.48 - $57.85 $42,565 - $50,792	-878 Reduced 2.8%	30,485 $1.56 Million
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $37,860 - $42,333	-654 Reduced 2.04%	31,363 $1.82 Million
Q2 2023 Jul 13, 2023	SELL	$63.71 - $70.74 $30,325 - $33,672	-476 Reduced 1.46%	32,017 $2.05 Million
Q1 2023 Apr 20, 2023	SELL	$65.71 - $74.53 $164,012 - $186,026	-2,496 Reduced 7.13%	32,493 $2.25 Million
Q4 2022 Jan 11, 2023	SELL	$68.48 - $81.09 $72,040 - $85,306	-1,052 Reduced 2.92%	34,989 $0
Q3 2022 Oct 19, 2022	SELL	$0.13 - $76.84 $230 - $136,314	-1,774 Reduced 4.69%	36,041 $2.56 Million
Q2 2022 Jul 11, 2022	SELL	$72.62 - $79.98 $100,070 - $110,212	-1,378 Reduced 3.52%	37,815 $2.91 Million
Q1 2022 Apr 13, 2022	SELL	$61.48 - $73.72 $82,752 - $99,227	-1,346 Reduced 3.32%	39,193 $2.86 Million
Q4 2021 Jan 14, 2022	BUY	$53.63 - $62.52 $58,081 - $67,709	1,083 Added 2.74%	40,539 $2.53 Million
Q3 2021 Oct 14, 2021	SELL	$59.17 - $69.31 $11,597 - $13,584	-196 Reduced 0.49%	39,456 $2.34 Million
Q2 2021 Jul 12, 2021	SELL	$61.91 - $67.42 $53,799 - $58,587	-869 Reduced 2.14%	39,652 $2.65 Million
Q1 2021 Apr 12, 2021	BUY	$59.34 - $66.74 $71,089 - $79,954	1,198 Added 3.05%	40,521 $2.56 Million
Q4 2020 Jan 11, 2021	SELL	$57.74 - $65.43 $8,661 - $9,814	-150 Reduced 0.38%	39,323 $2.44 Million
Q3 2020 Oct 09, 2020	SELL	$57.43 - $63.64 $23,546 - $26,092	-410 Reduced 1.03%	39,473 $2.38 Million
Q2 2020 Jul 08, 2020	SELL	$54.82 - $64.09 $40,402 - $47,234	-737 Reduced 1.81%	39,883 $2.35 Million
Q1 2020 Apr 06, 2020	SELL	$46.4 - $67.43 $5,243 - $7,619	-113 Reduced 0.28%	40,620 $2.26 Million
Q4 2019 Jan 09, 2020	BUY	$49.21 - $64.19 $146,104 - $190,580	2,969 Added 7.86%	40,733 $2.62 Million
Q3 2019 Oct 15, 2019	SELL	$42.77 - $50.71 $22,069 - $26,166	-516 Reduced 1.35%	37,764 $1.92 Million
Q2 2019 Jul 10, 2019	BUY	$44.62 - $49.34 $97,717 - $108,054	2,190 Added 6.07%	38,280 $1.75 Million
Q1 2019 Apr 08, 2019	SELL	$45.12 - $53.8 $90,375 - $107,761	-2,003 Reduced 5.26%	36,090 $1.72 Million
Q4 2018 Jan 17, 2019	BUY	$48.76 - $63.23 $48,077 - $62,344	986 Added 2.66%	38,093 $1.98 Million
Q3 2018 Oct 04, 2018	SELL	$55.19 - $62.25 $20,365 - $22,970	-369 Reduced 0.98%	37,107 $2.3 Million
Q2 2018 Jul 12, 2018	BUY	$50.53 - $62.98 $2,122 - $2,645	42 Added 0.11%	37,476 $2.07 Million
Q1 2018 Apr 11, 2018	SELL	$59.92 - $68.98 $33,854 - $38,973	-565 Reduced 1.49%	37,434 $2.37 Million
Q4 2017 Jan 10, 2018	SELL	$59.94 - $65.35 $100,998 - $110,114	-1,685 Reduced 4.25%	37,999 $2.33 Million
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $2.19 Million - $2.53 Million	39,684	39,684 $2.53 Million

Others Institutions Holding BMY

# of Institutions

2,751

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Triangle Securities Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Triangle Securities Wealth Management with notifications on news.

Account

Triangle Securities Wealth Management Bristol Myers Squibb CO Transaction History